Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Luminescence-based complementation assay to assess target engagement and cell permeability of glycolate oxidase (HAO1) inhibitors.

Mackinnon SR. et al, (2024), Biochimie

Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist

Balıkçı E. et al, (2024), Journal of Medicinal Chemistry, 67, 7245 - 7259

Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor.

Xiong Y. et al, (2024), Journal of medicinal chemistry

Regulation of inositol 5-phosphatase activity by the C2 domain of SHIP1 and SHIP2

Bradshaw WJ. et al, (2024), Structure

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.

Bashore FM. et al, (2024), PloS one, 19

Discovery of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic approach for Alzheimer's disease.

Du Y. et al, (2023), The Journal of biological chemistry

Structural Premise of Selective Deubiquitinase USP30 Inhibition by Small-Molecule Benzosulfonamides

O'Brien DP. et al, (2023), Molecular & Cellular Proteomics, 22, 100609 - 100609

The X-linked histone demethylases KDM5C and KDM6A as regulators of T cell-driven autoimmunity in the central nervous system.

Fazazi MR. et al, (2023), Brain research bulletin

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM.

Bashore FM. et al, (2023), bioRxiv

Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease.

Du Y. et al, (2023), bioRxiv

Open drug discovery in Alzheimer's disease.

Axtman AD. et al, (2023), Alzheimer's & dementia (New York, N. Y.), 9

Data from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Data from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Dataset S1 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Dataset S1 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Dataset S2 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Dataset S2 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Dataset S3 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Dataset S3 from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Supplementary Information from Inhibition of Histone H3K27 Demethylases Inactivates Brachyury (TBXT) and Promotes Chordoma Cell Death

Cottone L. et al, (2023)

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?